Crossref
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine
Neurology Letters · 2024
DOI: 10.61186/nl.3.1.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Letters, 2024. Verfasst von Mohammad Balabandian und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Balabandian, M., Mohammadi, M., & Mallahzadeh, A. (2024). The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine. Neurology Letters. https://doi.org/10.61186/nl.3.1.3
Vancouver
Balabandian M, Mohammadi M, Mallahzadeh A. The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine. Neurology Letters. 2024. doi:10.61186/nl.3.1.3
BibTeX
@article{Balabandian2024,
author = {Balabandian, Mohammad and Mohammadi, Mobin and Mallahzadeh, Arashk},
title = {The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine},
journal = {Neurology Letters},
year = {2024},
doi = {10.61186/nl.3.1.3}
}
EUVIMED